Please login to the form below

Not currently logged in
Email:
Password:

BACE inhibitors

This page shows the latest BACE inhibitors news and features for those working in and with pharma, biotech and healthcare.

Biogen, Eisai cue up BAN2401 readout in Alzheimer’s in 2022

Biogen, Eisai cue up BAN2401 readout in Alzheimer’s in 2022

The additional study could also include an arm combining BAN2401 with Eisai’s BACE inhibitor elenbecestat, a drug class that has also seen a string of failures in late-stage testing ... BACE inhibitors are designed to an enzyme involved in the

Latest news

More from news
Approximately 2 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimer’s advances

    we need more data on the efficacy of other approaches, including beta secretase cleaving enzyme (BACE) inhibitors which may reduce amyloid formation, rather than targeting its removal like the antibody strategies.”. ... Big pharma backing BACE. A

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics